African Journal of Infectious Diseases Research

ISSN 2756-3340

Table of Contents 2025

African Journal of Infectious Diseases Research | Vol. 12, No. 4, April 2025 | pp. 265-276

DOI: 10.46882/AJIDR/148723

Article Type: Research Article

Title: Molecular epidemiology and rotavirus vaccine impact on acute dehydrating diarrhea in infants and young children

Names of Authors: Akiko Watanabe¹, Kwabena Boateng², Martin Keller³*

Authors’ Affiliations: ¹Department of Virology, Osaka University, Osaka, Japan. ²Department of Child Health, University of Ghana Medical School, Accra, Ghana. ³Institute of Medical Virology, University of Zurich, Zurich, Switzerland.

Abstract: Group A rotavirus is a leading cause of severe gastroenteritis in children under five years, though national immunization programs have altered genotype dynamics. We investigated the prevalence and circulating genotypes of rotavirus among children hospitalized with acute watery diarrhea post-vaccine introduction. Stool samples from 440 children were tested using enzyme immunoassay and reverse transcription PCR genotyping. Rotavirus was detected in 21.8 percent of cases, representing a marked decline compared to pre-vaccination baselines, with G3P[8] (41.7 percent) and G12P[6] (26.0 percent) predominating. Unvaccinated infants experienced significantly higher dehydration severity scores and longer hospital stays than fully immunized peers. Sustaining high rotavirus vaccine coverage and ongoing genotype surveillance are critical to preventing strain replacement outbreaks.

Keywords: Rotavirus, Acute gastroenteritis, Vaccine impact, Genotyping, Pediatric diarrhea

Citation: Watanabe A, Boateng K, Keller M (2026). Molecular epidemiology and rotavirus vaccine impact on acute dehydrating diarrhea in infants and young children. African Journal of Infectious Diseases Research, 12(4): 265–276. DOI: 10.46882/AJIDR/148723

Manuscript Timeline: Received: February 28, 2026; Revised: March 31, 2026; Accepted: April 16, 2026; Published: April 30, 2026

African Journal of Infectious Diseases Research | Vol. 12, No. 4, April 2025 | pp. 253-264

DOI: 10.46882/AJIDR/148722

Article Type: Research Article

Title: Seroprevalence and zoonotic transmission risk of Brucella species among pastoralists and livestock handlers in semi-arid regions

Names of Authors: Ibrahim Musa¹, Helena Lindholm², Diego Montoya³*

Authors’ Affiliations: ¹Department of Veterinary Public Health, Ahmadu Bello University, Zaria, Nigeria. ²Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden. ³School of Veterinary Medicine, University of Antioquia, Medellín, Colombia.

Abstract: Brucellosis remains an underdiagnosed zoonotic disease causing chronic febrile illness and economic hardship in pastoral communities. This study aimed to determine the seroprevalence of Brucella infection and identify occupational risk factors among livestock handlers. Blood samples from 520 pastoralists were screened using the Rose Bengal plate test and confirmed via competitive ELISA and blood culture. Brucella seropositivity was detected in 18.5 percent of participants, with Brucella melitensis isolated in 6.2 percent of acute febrile cases. Consumption of unpasteurized milk, assisting with animal parturition without protective gloves, and close herd contact were independent predictors of infection. Coordinated livestock vaccination programs, milk pasteurization campaigns, and occupational hygiene education are urgently needed.

Keywords: Brucellosis, Zoonotic transmission, Seroprevalence, Pastoralists, Brucella melitensis

Citation: Musa I, Lindholm H, Montoya D (2026). Seroprevalence and zoonotic transmission risk of Brucella species among pastoralists and livestock handlers in semi-arid regions. African Journal of Infectious Diseases Research, 12(4): 253–264. DOI: 10.46882/AJIDR/148722

Manuscript Timeline: Received: February 27, 2026; Revised: March 30, 2026; Accepted: April 15, 2026; Published: April 30, 2026

African Journal of Infectious Diseases Research | Vol. 12, No. 4, April 2025 | pp. 241-252

DOI: 10.46882/AJIDR/148721

Article Type: Research Article

Title: Antimicrobial resistance genes and virulence factors in uropathogenic Escherichia coli causing recurrent community-acquired cystitis

Names of Authors: Olivia Vance¹, Mohammed Al-Ghamdi², João Pereira³*

Authors’ Affiliations: ¹Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand. ²Department of Clinical Laboratory Sciences, King Abdulaziz University, Jeddah, Saudi Arabia. ³Faculty of Pharmacy, University of Porto, Porto, Portugal.

Abstract: Uropathogenic Escherichia coli is the primary causative agent of uncomplicated and recurrent urinary tract infections worldwide. In this study, we characterized antimicrobial resistance determinants and virulence gene profiles among E. coli isolates from women with recurrent cystitis. Midstream urine cultures from 450 outpatient women yielded 312 confirmed E. coli isolates, which underwent susceptibility testing and multiplex PCR for virulence and resistance genes. Multidrug resistance was observed in 42.6 percent of isolates, with blaCTX-M-15 detected in 28.5 percent and qnrS genes in 19.9 percent. P-fimbriae (papC) and aerobactin (iutA) virulence genes were significantly enriched in strains causing three or more annual recurrences. Culture-guided antibiotic selection and non-antibiotic prophylactic strategies are recommended to limit resistance escalation.

Keywords: Uropathogenic Escherichia coli, Urinary tract infection, Antimicrobial resistance, Virulence factors, Extended-spectrum beta-lactamase

Citation: Vance O, Al-Ghamdi M, Pereira J (2026). Antimicrobial resistance genes and virulence factors in uropathogenic Escherichia coli causing recurrent community-acquired cystitis. African Journal of Infectious Diseases Research, 12(4): 241–252. DOI: 10.46882/AJIDR/148721

Manuscript Timeline: Received: February 26, 2026; Revised: March 29, 2026; Accepted: April 14, 2026; Published: April 30, 2026

African Journal of Infectious Diseases Research | Vol. 12, No. 4, April 2025 | pp. 229-240

DOI: 10.46882/AJIDR/148720

Article Type: Research Article

Title: Viral hepatitis E seroprevalence and acute liver failure outcomes among pregnant women in peri-urban settlements

Names of Authors: Farhan Siddiqui¹, Beatrice Mensah², Emilie Bergeron³*

Authors’ Affiliations: ¹Department of Gastroenterology and Hepatology, Aga Khan University, Karachi, Pakistan. ²Department of Obstetrics and Gynecology, University of Health and Allied Sciences, Ho, Ghana. ³Department of Global Health, Université Laval, Quebec City, Canada.

Abstract: Hepatitis E virus infection during pregnancy is associated with fulminant hepatic failure and high maternal and fetal mortality in waterborne endemic zones. We investigated the seroprevalence of acute hepatitis E infection and clinical outcomes among pregnant women presenting with acute jaundice. Serum samples from 275 jaundiced pregnant women were screened for anti-HEV IgM and HEV RNA using ELISA and quantitative PCR. Acute hepatitis E was confirmed in 39.6 percent of cases, with genotype 1 accounting for all sequenced strains. Fulminant hepatic failure developed in 21.1 percent of infected women, resulting in a maternal case fatality rate of 16.5 percent, predominantly in the third trimester. Safe drinking water provision, prenatal hygiene education, and accelerated maternal vaccine deployment are urgent public health priorities.

Keywords: Hepatitis E virus, Pregnancy, Acute liver failure, Maternal mortality, Waterborne infection

Citation: Siddiqui F, Mensah B, Bergeron E (2026). Viral hepatitis E seroprevalence and acute liver failure outcomes among pregnant women in peri-urban settlements. African Journal of Infectious Diseases Research, 12(4): 229–240. DOI: 10.46882/AJIDR/148720

Manuscript Timeline: Received: February 25, 2026; Revised: March 28, 2026; Accepted: April 13, 2026; Published: April 30, 2026

African Journal of Infectious Diseases Research | Vol. 12, No. 4, April 2025 | pp. 217-228

DOI: 10.46882/AJIDR/148719

Article Type: Research Article

Title: Diagnostic accuracy of urinary lipoarabinomannan lateral flow assays for disseminated tuberculosis in hospitalized patients

Names of Authors: Sipho Dlamini¹, Hiroki Sato², Chiara Bianchi³*

Authors’ Affiliations: ¹Department of Internal Medicine, University of KwaZulu-Natal, Durban, South Africa. ²Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Tokyo, Japan. ³Department of Infectious Diseases, University of Bologna, Bologna, Italy.

Abstract: Disseminated tuberculosis is frequently missed by conventional sputum-based diagnostics, leading to delayed treatment and high inpatient mortality. This study assessed the diagnostic performance of a next-generation urinary lipoarabinomannan assay compared against mycobacterial blood and sputum cultures. Urine, sputum, and blood samples were collected from 410 hospitalized adults with suspected extrapulmonary or disseminated tuberculosis. The urinary lipoarabinomannan assay demonstrated an overall sensitivity of 68.4 percent and specificity of 94.2 percent, increasing to 79.5 percent sensitivity among patients with severe immunosuppression. Turnaround time from specimen collection to actionable result averaged thirty-five minutes compared to twenty-one days for liquid culture. Integrating point-of-care urinary antigen testing into inpatient admission workflows accelerates anti-tuberculosis treatment initiation.

Keywords: Disseminated tuberculosis, Lipoarabinomannan, Point-of-care diagnostics, Extrapulmonary tuberculosis, Diagnostic accuracy

Citation: Dlamini S, Sato H, Bianchi C (2026). Diagnostic accuracy of urinary lipoarabinomannan lateral flow assays for disseminated tuberculosis in hospitalized patients. African Journal of Infectious Diseases Research, 12(4): 217–228. DOI: 10.46882/AJIDR/148719

Manuscript Timeline: Received: February 24, 2026; Revised: March 27, 2026; Accepted: April 12, 2026; Published: April 30, 2026

African Journal of Infectious Diseases Research | Vol. 12, No. 4, April 2025 | pp. 205-216

DOI: 10.46882/AJIDR/148718

Article Type: Research Article

Title: Seroprevalence and risk factors of Toxoplasma gondii infection among HIV-positive adults with neurological symptoms

Names of Authors: Rodrigo Castillo¹, Esther Kamau², Thomas Lindner³*

Authors’ Affiliations: ¹Institute of Biomedical Research, University of Buenos Aires, Buenos Aires, Argentina. ²Department of Medical Microbiology, University of Nairobi, Nairobi, Kenya. ³Institute of Medical Microbiology, University of Vienna, Vienna, Austria.

Abstract: Cerebral toxoplasmosis is the most common opportunistic central nervous system infection in severely immunocompromised individuals living with HIV. We evaluated the seroprevalence of Toxoplasma gondii antibodies and clinical predictors of cerebral toxoplasmosis among HIV-positive adults presenting with neurological deficits. Serum samples from 315 patients were tested for anti-Toxoplasma IgG and IgM antibodies alongside neuroimaging and CD4 T-cell count assessments. Latent Toxoplasma IgG seropositivity was found in 58.7 percent of participants, and active cerebral toxoplasmosis was diagnosed in 16.5 percent of the cohort. A CD4 count below 100 cells per microliter and lack of cotrimoxazole prophylaxis were independently associated with active disease. Early HIV diagnosis, universal cotrimoxazole preventive therapy, and prompt neuroimaging are vital to preventing fatal neurological complications.

Keywords: Toxoplasma gondii, Cerebral toxoplasmosis, HIV/AIDS, Opportunistic infections, Cotrimoxazole prophylaxis

Citation: Castillo R, Kamau E, Lindner T (2026). Seroprevalence and risk factors of Toxoplasma gondii infection among HIV-positive adults with neurological symptoms. African Journal of Infectious Diseases Research, 12(4): 205–216. DOI: 10.46882/AJIDR/148718

Manuscript Timeline: Received: February 23, 2026; Revised: March 26, 2026; Accepted: April 11, 2026; Published: April 30, 2026